$CRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Get notifications about new insider transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | A | 337.99 | 18,869 | 6,377,533 | 18,869 | |
Jun 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 337.99 | 1,273 | 430,261 | 214,799 | 216.1 K to 214.8 K (-0.59 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 323.29 | 1 | 323 | 5,355 | 5.4 K to 5.4 K (-0.02 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 321.06 | 110 | 35,316 | 5,356 | 5.5 K to 5.4 K (-2.01 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 320.19 | 174 | 55,713 | 5,466 | 5.6 K to 5.5 K (-3.09 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 319.42 | 56 | 17,888 | 5,640 | 5.7 K to 5.6 K (-0.98 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 316.75 | 30 | 9,502 | 5,696 | 5.7 K to 5.7 K (-0.52 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 323.29 | 1 | 323 | 5,355 | 5.4 K to 5.4 K (-0.02 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 321.06 | 110 | 35,316 | 5,356 | 5.5 K to 5.4 K (-2.01 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 320.19 | 174 | 55,713 | 5,466 | 5.6 K to 5.5 K (-3.09 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 319.42 | 56 | 17,888 | 5,640 | 5.7 K to 5.6 K (-0.98 %) |
May 12 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 316.75 | 30 | 9,502 | 5,696 | 5.7 K to 5.7 K (-0.52 %) |
May 11 2021 | CRL | CHARLES RIVER LABO ... | WILSON VIRGINIA M | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 11 2021 | CRL | CHARLES RIVER LABO ... | WILSON VIRGINIA M | Director | Grant | A | 0.00 | 355 | 0 | 2,167 | 1.8 K to 2.2 K (+19.59 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 219 | 0 | 32,289 | 32.1 K to 32.3 K (+0.68 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 355 | 0 | 32,070 | 31.7 K to 32.1 K (+1.12 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 234 | 0 | 63,478 | 63.2 K to 63.5 K (+0.37 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 355 | 0 | 63,244 | 62.9 K to 63.2 K (+0.56 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 307 | 0 | 29,079 | 28.8 K to 29.1 K (+1.07 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 355 | 0 | 28,772 | 28.4 K to 28.8 K (+1.25 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Grant | A | 0.00 | 355 | 0 | 5,726 | 5.4 K to 5.7 K (+6.61 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 219 | 0 | 9,599 | 9.4 K to 9.6 K (+2.33 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 355 | 0 | 9,380 | 9 K to 9.4 K (+3.93 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Llado George Sr. | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Llado George Sr. | Director | Grant | A | 0.00 | 175 | 0 | 953 | 778 to 953 (+22.49 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Llado George Sr. | Director | Grant | A | 0.00 | 355 | 0 | 778 | 423 to 778 (+83.92 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Grant | A | 0.00 | 355 | 0 | 7,083 | 6.7 K to 7.1 K (+5.28 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Grant | A | 0.00 | 248 | 0 | 29,737 | 29.5 K to 29.7 K (+0.84 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Grant | A | 0.00 | 355 | 0 | 29,489 | 29.1 K to 29.5 K (+1.22 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Grant | A | 0.00 | 355 | 0 | 1,220 | 865 to 1.2 K (+41.04 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 345.85 | 606 | 209,582 | 216,072 | 216.7 K to 216.1 K (-0.28 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 344.60 | 1,300 | 447,976 | 216,678 | 218 K to 216.7 K (-0.60 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 343.55 | 2,008 | 689,841 | 217,978 | 220 K to 218 K (-0.91 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 342.42 | 1,102 | 377,347 | 219,986 | 221.1 K to 220 K (-0.50 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 341.80 | 2,484 | 849,025 | 221,088 | 223.6 K to 221.1 K (-1.11 %) |
May 07 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 338.98 | 600 | 203,386 | 5,371 | 6 K to 5.4 K (-10.05 %) |
May 07 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 338.06 | 288 | 97,362 | 5,971 | 6.3 K to 6 K (-4.60 %) |
May 07 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 336.84 | 910 | 306,522 | 6,259 | 7.2 K to 6.3 K (-12.69 %) |
May 07 2021 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 336.06 | 1,572 | 528,290 | 7,169 | 8.7 K to 7.2 K (-17.98 %) |
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 144.67 | 3,305 | 478,134 | 6,609 | |
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 340.01 | 3,305 | 1,123,718 | 14,862 | 18.2 K to 14.9 K (-18.19 %) |
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 144.67 | 3,305 | 478,134 | 18,167 | 14.9 K to 18.2 K (+22.24 %) |
May 04 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 332.45 | 93 | 30,918 | 3,959 | 4.1 K to 4 K (-2.30 %) |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 109.34 | 3,845 | 420,412 | 3,846 | |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 330.00 | 3,845 | 1,268,850 | 14,862 | 18.7 K to 14.9 K (-20.55 %) |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 109.34 | 3,845 | 420,412 | 18,707 | 14.9 K to 18.7 K (+25.87 %) |
Apr 16 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 320.00 | 2,000 | 640,000 | 14,862 | 16.9 K to 14.9 K (-11.86 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 144.67 | 5,916 | 855,868 | 5,916 | |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 109.34 | 6,409 | 700,760 | 3,205 | |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 88.05 | 5,986 | 527,067 | 0 | |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 88.05 | 999 | 87,962 | 5,986 | |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 304.85 | 5,916 | 1,803,493 | 29,060 | 35 K to 29.1 K (-16.91 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 144.67 | 5,916 | 855,868 | 34,976 | 29.1 K to 35 K (+20.36 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 304.85 | 6,409 | 1,953,784 | 29,060 | 35.5 K to 29.1 K (-18.07 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 109.34 | 6,409 | 700,760 | 35,469 | 29.1 K to 35.5 K (+22.05 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 298.00 | 5,986 | 1,783,828 | 29,060 | 35 K to 29.1 K (-17.08 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 88.05 | 5,986 | 527,067 | 35,046 | 29.1 K to 35 K (+20.60 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 298.00 | 999 | 297,702 | 29,060 | 30.1 K to 29.1 K (-3.32 %) |
Apr 07 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 88.05 | 999 | 87,962 | 30,059 | 29.1 K to 30.1 K (+3.44 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Sell | S | 290.01 | 3,530 | 1,023,730 | 28,417 | 31.9 K to 28.4 K (-11.05 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Sell | S | 290.01 | 3,530 | 1,023,730 | 28,417 | 31.9 K to 28.4 K (-11.05 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Buy | M | 52.29 | 3,530 | 184,584 | 31,947 | 28.4 K to 31.9 K (+12.42 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Buy | M | 52.29 | 3,530 | 184,584 | 31,947 | 28.4 K to 31.9 K (+12.42 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | M | 88.05 | 3,493 | 307,559 | 0 | |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 290.43 | 1,157 | 336,028 | 16,975 | 18.1 K to 17 K (-6.38 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 290.10 | 3,493 | 1,013,312 | 3,818 | 7.3 K to 3.8 K (-47.78 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Buy | M | 88.05 | 3,493 | 307,559 | 7,311 | 3.8 K to 7.3 K (+91.49 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 1,157 | 0 | 18,132 | 17 K to 18.1 K (+6.82 %) |
Mar 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 1,157 | 0 | 3,818 | 5 K to 3.8 K (-23.26 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 282.98 | 322 | 91,120 | 29,060 | 29.4 K to 29.1 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 88.05 | 24,009 | 2,113,992 | 0 | |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 289.02 | 255 | 73,700 | 221,151 | 221.4 K to 221.2 K (-0.12 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 288.33 | 2,466 | 711,029 | 221,406 | 223.9 K to 221.4 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.58 | 2,752 | 791,427 | 223,872 | 226.6 K to 223.9 K (-1.21 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 286.45 | 4,485 | 1,284,744 | 226,624 | 231.1 K to 226.6 K (-1.94 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.48 | 1,993 | 568,955 | 231,109 | 233.1 K to 231.1 K (-0.85 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.63 | 2,646 | 753,138 | 233,102 | 235.7 K to 233.1 K (-1.12 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 283.53 | 2,278 | 645,890 | 235,748 | 238 K to 235.7 K (-0.96 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.49 | 2,656 | 750,280 | 238,026 | 240.7 K to 238 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.65 | 2,191 | 617,096 | 240,682 | 242.9 K to 240.7 K (-0.90 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.41 | 1,234 | 346,028 | 242,873 | 244.1 K to 242.9 K (-0.51 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.51 | 1,053 | 294,320 | 244,107 | 245.2 K to 244.1 K (-0.43 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 88.05 | 24,009 | 2,113,992 | 245,160 | 221.2 K to 245.2 K (+10.86 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 282.98 | 2,210 | 625,386 | 221,151 | 223.4 K to 221.2 K (-0.99 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 282.98 | 322 | 91,120 | 17,246 | 17.6 K to 17.2 K (-1.83 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 282.98 | 289 | 81,781 | 16,862 | 17.2 K to 16.9 K (-1.69 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 5,297 | 5.6 K to 5.3 K (-5.61 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 289.55 | 287 | 83,101 | 5,612 | 5.9 K to 5.6 K (-4.87 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 7,154 | 0 | 16,975 | 9.8 K to 17 K (+72.84 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 7,154 | 0 | 5,899 | 13.1 K to 5.9 K (-54.81 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 109.34 | 20,295 | 2,219,055 | 20,296 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 144.67 | 17,436 | 2,522,466 | 34,872 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.78 | 984 | 278,255 | 223,361 | 224.3 K to 223.4 K (-0.44 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.91 | 2,832 | 798,358 | 224,345 | 227.2 K to 224.3 K (-1.25 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.96 | 4,259 | 1,196,590 | 227,177 | 231.4 K to 227.2 K (-1.84 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.97 | 6,474 | 1,812,519 | 231,436 | 237.9 K to 231.4 K (-2.72 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.31 | 925 | 258,366 | 237,910 | 238.8 K to 237.9 K (-0.39 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 278.07 | 1,249 | 347,310 | 238,835 | 240.1 K to 238.8 K (-0.52 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 277.00 | 1,809 | 501,095 | 240,084 | 241.9 K to 240.1 K (-0.75 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 276.03 | 1,309 | 361,323 | 241,893 | 243.2 K to 241.9 K (-0.54 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 274.81 | 454 | 124,762 | 243,202 | 243.7 K to 243.2 K (-0.19 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 109.34 | 20,295 | 2,219,055 | 243,656 | 223.4 K to 243.7 K (+9.09 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 283.59 | 1,994 | 565,478 | 223,361 | 225.4 K to 223.4 K (-0.88 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 289.55 | 1,814 | 525,244 | 225,355 | 227.2 K to 225.4 K (-0.80 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.79 | 52 | 14,861 | 227,169 | 227.2 K to 227.2 K (-0.02 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.50 | 4,240 | 1,206,283 | 227,221 | 231.5 K to 227.2 K (-1.83 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 283.56 | 4,020 | 1,139,911 | 231,461 | 235.5 K to 231.5 K (-1.71 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.49 | 5,476 | 1,546,929 | 235,481 | 241 K to 235.5 K (-2.27 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.69 | 2,223 | 626,190 | 240,957 | 243.2 K to 241 K (-0.91 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.66 | 1,425 | 399,944 | 243,180 | 244.6 K to 243.2 K (-0.58 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 144.67 | 17,436 | 2,522,466 | 244,605 | 227.2 K to 244.6 K (+7.68 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 281.66 | 658 | 185,330 | 40,529 | 41.2 K to 40.5 K (-1.60 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Buy | M | 52.29 | 3,530 | 184,584 | 41,187 | 37.7 K to 41.2 K (+9.37 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 17,568 | 17.9 K to 17.6 K (-1.76 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 289.55 | 317 | 91,787 | 17,883 | 18.2 K to 17.9 K (-1.74 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 17,568 | 17.9 K to 17.6 K (-1.76 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 289.55 | 317 | 91,787 | 17,883 | 18.2 K to 17.9 K (-1.74 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 289.55 | 121 | 35,036 | 5,507 | 5.6 K to 5.5 K (-2.15 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 73.70 | 1,675 | 123,448 | 0 | |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 29,382 | 29.7 K to 29.4 K (-1.06 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 289.55 | 308 | 89,181 | 29,697 | 30 K to 29.7 K (-1.03 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 293.92 | 1,675 | 492,311 | 30,005 | 31.7 K to 30 K (-5.29 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 73.70 | 1,675 | 123,448 | 31,680 | 30 K to 31.7 K (+5.58 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 283.59 | 84 | 23,822 | 4,052 | 4.1 K to 4.1 K (-2.03 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 289.55 | 62 | 17,952 | 4,136 | 4.2 K to 4.1 K (-1.48 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Sell | S | 290.99 | 410 | 119,305 | 4,198 | 4.6 K to 4.2 K (-8.90 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 283.59 | 272 | 77,136 | 17,031 | 17.3 K to 17 K (-1.57 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 289.55 | 247 | 71,519 | 17,303 | 17.6 K to 17.3 K (-1.41 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 292.37 | 1,149 | 335,937 | 0 | 1.1 K to 0 (-100.00 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 291.83 | 1,400 | 408,558 | 1,149 | 2.5 K to 1.1 K (-54.92 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 290.03 | 6,107 | 1,771,191 | 2,549 | 8.7 K to 2.5 K (-70.55 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 289.16 | 31 | 8,964 | 227,169 | 227.2 K to 227.2 K (-0.01 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.99 | 2,402 | 691,753 | 227,200 | 229.6 K to 227.2 K (-1.05 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.18 | 4,775 | 1,371,289 | 229,602 | 234.4 K to 229.6 K (-2.04 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 286.48 | 2,490 | 713,343 | 234,377 | 236.9 K to 234.4 K (-1.05 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.15 | 9,643 | 2,749,723 | 236,867 | 246.5 K to 236.9 K (-3.91 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.21 | 4,038 | 1,147,634 | 246,510 | 250.5 K to 246.5 K (-1.61 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.96 | 727 | 205,714 | 250,548 | 251.3 K to 250.5 K (-0.29 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.39 | 3,766 | 1,063,485 | 251,275 | 255 K to 251.3 K (-1.48 %) |